Advancing Non-Invasive Healthcare

Helping genomic healthcare professionals and researchers improve patient care through validated cell-free DNA solutions.

Advancing Non-Invasive Healthcare

Helping genomic healthcare professionals and researchers improve patient care through validated cell-free DNA solutions.

banner

Our Products

See our range of cfDNA products below.

Pre-Analytical

Ensuring successful cfDNA analysis is our focus

Every sample is precious and to get the most out of your sample when evaluating cfDNA it is really critical to have processed your samples correctly from blood collection through to extracted cfDNA. Learn more about our Cell3 Preserver blood tube and Cell3 Xtract kit below.

Prenatal Healthcare

Non-invasive prenatal testing requires sensitive, reproducible and easy to use products.

Nonacus continues to develop innovative products to meet these exacting standards including tests for fetal rhesus-D genotyping, fetal fraction quantitation and single gene disorder testing.

Oncology

Efficient workflow enables confident calling of all ctDNA mutations

Nonacus are working with some of the brightest scientists and clinicians by providing a validated complete workflow for liquid biopsy analysis. With the ultimate goal of enabling better cancer care through earlier diagnosis, treatment stratification and monitoring.

Who we are

Designed by scientists, for Scientists

We are formed of a committed group of biotechnology professionals with a combined 35 years experience in genomic healthcare. We understand the pressure on laboratories to deliver progress and our products are designed to get you there. Between us, we’ve got global experience of genomic healthcare from the NHS in the UK through to an international genome project.

Designed-by-Scientists
True-Innovation-that-benefits-e1512081590877

What we stand for

True Innovation That Benefits Patients

We translate research into routine diagnostic tools that directly benefit patients and scientists. Our non-invasive cell free DNA solutions improve diagnostic accuracy as well as the patient’s experience. Our research & development team are constantly developing, validating and testing new cfDNA products.

Built For Labs That Do

Universities

We supply Universities with our cfDNA products to help them improve their understanding and research in non-invasive healthcare.

Hospitals

Leading hospitals have adopted our products to help improve patient care through the innovative use of cfDNA technology allowing for non-invasive diagnostics.

Research Facilities

We partner with many leading laboratories to constantly innovate and push our products further.

built-for-labs-that-do

Read Our Latest Insights

New QA / QC Production Scientist Role at Nonacus

June 18, 2018

We are excited to announce that Nonacus are recruiting! Following the successful launch of our Cell3TM DNA product range we are now growing the team and are seeking a highly motivated experienced Quality Assurance (QA) / Quality Control (QC) Production Scientist to join our team. The full job description and details on how to apply…

Read More

Nonacus works with leading NHS laboratory on validating innovative product

November 22, 2017

New direct from plasma cfDNA test provides results in three hours. Since 2011 the NHS has been using cell free DNA (cfDNA) in fetal sex testing to identify pregnancies at high risk of sex-linked disorders. This test is done by extracting cfDNA from maternal plasma: a process that is slowing down results for patients.

Read More

NIPD of fetal RhD takes step closer to EQA

November 22, 2017

Nonacus reviews latest accreditation efforts. Currently, the RhD genotyping landscape doesn’t feature a full EQA (European Quality Assurance) scheme but this latest report published in Blood Transfusion represents a big step forward towards an EQA. The authors have set themselves an objective to implement a regular EQA scheme through their working group. Chris Sale- CEO

Read More

Are you ready to innovate your cfDNA capability?

Contact us for a quote.